Table of Contents 1 Market Overview 1.1 Drugs for Malaria Introduction 1.2 Market Analysis by Type 1.2.1 Aryl Aminoalcohol Compounds 1.2.2 Antifolate Compounds 1.2.3 Artemisinin Compounds 1.3 Market Analysis by Applications 1.3.1 Prevention 1.3.2 Treatment 1.3.3 Other 1.4 Market Analysis by Regions 1.4.1 North America (USA, Canada and Mexico) 1.4.1.1 USA Market States and Outlook (2012-2022) 1.4.1.2 Canada Market States and Outlook (2012-2022) 1.4.1.3 Mexico Market States and Outlook (2012-2022) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2012-2022) 1.4.2.2 France Market States and Outlook (2012-2022) 1.4.2.3 UK Market States and Outlook (2012-2022) 1.4.2.4 Russia Market States and Outlook (2012-2022) 1.4.2.5 Italy Market States and Outlook (2012-2022) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2012-2022) 1.4.3.2 Japan Market States and Outlook (2012-2022) 1.4.3.3 Korea Market States and Outlook (2012-2022) 1.4.3.4 India Market States and Outlook (2012-2022) 1.4.3.5 Southeast Asia Market States and Outlook (2012-2022) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2012-2022) 1.4.4.2 Egypt Market States and Outlook (2012-2022) 1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022) 1.4.4.4 South Africa Market States and Outlook (2012-2022) 1.4.4.5 Nigeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Cipla 2.1.1 Business Overview 2.1.2 Drugs for Malaria Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Guilin Pharmaceutical 2.2.1 Business Overview 2.2.2 Drugs for Malaria Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 IPCA Laboratories 2.3.1 Business Overview 2.3.2 Drugs for Malaria Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 GlaxoSmithKline 2.4.1 Business Overview 2.4.2 Drugs for Malaria Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Mylan Labs 2.5.1 Business Overview 2.5.2 Drugs for Malaria Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Roche 2.6.1 Business Overview 2.6.2 Drugs for Malaria Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Novartis 2.7.1 Business Overview 2.7.2 Drugs for Malaria Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Sanofi Aventis 2.8.1 Business Overview 2.8.2 Drugs for Malaria Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Ajanta Pharma 2.9.1 Business Overview 2.9.2 Drugs for Malaria Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Drugs for Malaria Market Competition, by Manufacturer 3.1 Global Drugs for Malaria Sales and Market Share by Manufacturer 3.2 Global Drugs for Malaria Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Drugs for Malaria Manufacturer Market Share 3.3.2 Top 6 Drugs for Malaria Manufacturer Market Share 3.4 Market Competition Trend 4 Global Drugs for Malaria Market Analysis by Regions 4.1 Global Drugs for Malaria Sales, Revenue and Market Share by Regions 4.1.1 Global Drugs for Malaria Sales by Regions (2012-2017) 4.1.2 Global Drugs for Malaria Revenue by Regions (2012-2017) 4.2 North America Drugs for Malaria Sales and Growth (2012-2017) 4.3 Europe Drugs for Malaria Sales and Growth (2012-2017) 4.4 Asia-Pacific Drugs for Malaria Sales and Growth (2012-2017) 4.5 South America Drugs for Malaria Sales and Growth (2012-2017) 4.6 Middle East and Africa Drugs for Malaria Sales and Growth (2012-2017) 5 North America Drugs for Malaria by Countries 5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Countries 5.1.1 North America Drugs for Malaria Sales by Countries (2012-2017) 5.1.2 North America Drugs for Malaria Revenue by Countries (2012-2017) 5.2 USA Drugs for Malaria Sales and Growth (2012-2017) 5.3 Canada Drugs for Malaria Sales and Growth (2012-2017) 5.4 Mexico Drugs for Malaria Sales and Growth (2012-2017) 6 Europe Drugs for Malaria by Countries 6.1 Europe Drugs for Malaria Sales, Revenue and Market Share by Countries 6.1.1 Europe Drugs for Malaria Sales by Countries (2012-2017) 6.1.2 Europe Drugs for Malaria Revenue by Countries (2012-2017) 6.2 Germany Drugs for Malaria Sales and Growth (2012-2017) 6.3 UK Drugs for Malaria Sales and Growth (2012-2017) 6.4 France Drugs for Malaria Sales and Growth (2012-2017) 6.5 Russia Drugs for Malaria Sales and Growth (2012-2017) 6.6 Italy Drugs for Malaria Sales and Growth (2012-2017) 7 Asia-Pacific Drugs for Malaria by Countries 7.1 Asia-Pacific Drugs for Malaria Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Drugs for Malaria Sales by Countries (2012-2017) 7.1.2 Asia-Pacific Drugs for Malaria Revenue by Countries (2012-2017) 7.2 China Drugs for Malaria Sales and Growth (2012-2017) 7.3 Japan Drugs for Malaria Sales and Growth (2012-2017) 7.4 Korea Drugs for Malaria Sales and Growth (2012-2017) 7.5 India Drugs for Malaria Sales and Growth (2012-2017) 7.6 Southeast Asia Drugs for Malaria Sales and Growth (2012-2017) 8 South America Drugs for Malaria by Countries 8.1 South America Drugs for Malaria Sales, Revenue and Market Share by Countries 8.1.1 South America Drugs for Malaria Sales by Countries (2012-2017) 8.1.2 South America Drugs for Malaria Revenue by Countries (2012-2017) 8.2 Brazil Drugs for Malaria Sales and Growth (2012-2017) 8.3 Argentina Drugs for Malaria Sales and Growth (2012-2017) 8.4 Columbia Drugs for Malaria Sales and Growth (2012-2017) 9 Middle East and Africa Drugs for Malaria by Countries 9.1 Middle East and Africa Drugs for Malaria Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Drugs for Malaria Sales by Countries (2012-2017) 9.1.2 Middle East and Africa Drugs for Malaria Revenue by Countries (2012-2017) 9.2 Saudi Arabia Drugs for Malaria Sales and Growth (2012-2017) 9.3 UAE Drugs for Malaria Sales and Growth (2012-2017) 9.4 Egypt Drugs for Malaria Sales and Growth (2012-2017) 9.5 Nigeria Drugs for Malaria Sales and Growth (2012-2017) 9.6 South Africa Drugs for Malaria Sales and Growth (2012-2017) 10 Global Drugs for Malaria Market Segment by Type 10.1 Global Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017) 10.1.1 Global Drugs for Malaria Sales and Market Share by Type (2012-2017) 10.1.2 Global Drugs for Malaria Revenue and Market Share by Type (2012-2017) 10.2 Aryl Aminoalcohol Compounds Sales Growth and Price 10.2.1 Global Aryl Aminoalcohol Compounds Sales Growth (2012-2017) 10.2.2 Global Aryl Aminoalcohol Compounds Price (2012-2017) 10.3 Antifolate Compounds Sales Growth and Price 10.3.1 Global Antifolate Compounds Sales Growth (2012-2017) 10.3.2 Global Antifolate Compounds Price (2012-2017) 10.4 Artemisinin Compounds Sales Growth and Price 10.4.1 Global Artemisinin Compounds Sales Growth (2012-2017) 10.4.2 Global Artemisinin Compounds Price (2012-2017) 11 Global Drugs for Malaria Market Segment by Application 11.1 Global Drugs for Malaria Sales Market Share by Application (2012-2017) 11.2 Prevention Sales Growth (2012-2017) 11.3 Treatment Sales Growth (2012-2017) 11.4 Other Sales Growth (2012-2017) 12 Drugs for Malaria Market Forecast (2017-2022) 12.1 Global Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022) 12.2 Drugs for Malaria Market Forecast by Regions (2017-2022) 12.2.1 North America Drugs for Malaria Market Forecast (2017-2022) 12.2.2 Europe Drugs for Malaria Market Forecast (2017-2022) 12.2.3 Asia-Pacific Drugs for Malaria Market Forecast (2017-2022) 12.2.4 South America Drugs for Malaria Market Forecast (2017-2022) 12.2.5 Middle East and Africa Drugs for Malaria Market Forecast (2017-2022) 12.3 Drugs for Malaria Market Forecast by Type (2017-2022) 12.4 Drugs for Malaria Market Forecast by Application (2017-2022) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Analyst Introduction 15.3 Data Source

List of Tables and Figures Figure Drugs for Malaria Picture Table Product Specifications of Drugs for Malaria Figure Global Sales Market Share of Drugs for Malaria by Types in 2016 Table Drugs for Malaria Types for Major Manufacturers Figure Aryl Aminoalcohol Compounds Picture Figure Antifolate Compounds Picture Figure Artemisinin Compounds Picture Table Drugs for Malaria Sales Market Share by Applications in 2016 Figure Prevention Picture Figure Treatment Picture Figure Other Picture Figure USA Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Canada Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Mexico Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Germany Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure France Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure UK Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Russia Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Italy Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure China Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Japan Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Korea Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure India Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Southeast Asia Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Brazil Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Drugs for Malaria Revenue (Value) and Growth Rate (2012-2022) Table Cipla Basic Information, Manufacturing Base and Competitors Table Cipla Drugs for Malaria Type and Applications Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Guilin Pharmaceutical Drugs for Malaria Type and Applications Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors Table IPCA Laboratories Drugs for Malaria Type and Applications Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Drugs for Malaria Type and Applications Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Mylan Labs Basic Information, Manufacturing Base and Competitors Table Mylan Labs Drugs for Malaria Type and Applications Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Drugs for Malaria Type and Applications Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Drugs for Malaria Type and Applications Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors Table Sanofi Aventis Drugs for Malaria Type and Applications Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors Table Ajanta Pharma Drugs for Malaria Type and Applications Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Drugs for Malaria Sales by Manufacturer (2016-2017) Figure Global Drugs for Malaria Sales Market Share by Manufacturer in 2016 Figure Global Drugs for Malaria Sales Market Share by Manufacturer in 2017 Table Global Drugs for Malaria Revenue by Manufacturer (2016-2017) Figure Global Drugs for Malaria Revenue Market Share by Manufacturer in 2016 Figure Global Drugs for Malaria Revenue Market Share by Manufacturer in 2017 Figure Global Drugs for Malaria Sales and Growth (2012-2017) Figure Global Drugs for Malaria Revenue and Growth (2012-2017) Table Global Drugs for Malaria Sales by Regions (2012-2017) Table Global Drugs for Malaria Sales Market Share by Regions (2012-2017) Table Global Drugs for Malaria Revenue by Regions (2012-2017) Table Global Drugs for Malaria Revenue Market Share by Regions in 2012 Table Global Drugs for Malaria Revenue Market Share by Regions in 2016 Figure North America Drugs for Malaria Sales and Growth (2012-2017) Figure Europe Drugs for Malaria Sales and Growth (2012-2017) Figure Asia-Pacific Drugs for Malaria Sales and Growth (2012-2017) Figure South America Drugs for Malaria Sales and Growth (2012-2017) Figure Middle East and Africa Drugs for Malaria Sales and Growth (2012-2017) Figure North America Drugs for Malaria Revenue and Growth (2012-2017) Table North America Drugs for Malaria Sales by Countries (2012-2017) Table North America Drugs for Malaria Sales Market Share by Countries (2012-2017) Figure North America Drugs for Malaria Sales Market Share by Countries in 2012 Figure North America Drugs for Malaria Sales Market Share by Countries in 2016 Table North America Drugs for Malaria Revenue by Countries (2012-2017) Table North America Drugs for Malaria Revenue Market Share by Countries (2012-2017) Figure North America Drugs for Malaria Revenue Market Share by Countries in 2012 Figure North America Drugs for Malaria Revenue Market Share by Countries in 2016 Figure USA Drugs for Malaria Sales and Growth (2012-2017) Figure Canada Drugs for Malaria Sales and Growth (2012-2017) Figure Mexico Drugs for Malaria Sales and Growth (2012-2017) Figure Europe Drugs for Malaria Revenue and Growth (2012-2017) Table Europe Drugs for Malaria Sales by Countries (2012-2017) Table Europe Drugs for Malaria Sales Market Share by Countries (2012-2017) Table Europe Drugs for Malaria Revenue by Countries (2012-2017) Table Europe Drugs for Malaria Revenue Market Share by Countries in 2012 Table Europe Drugs for Malaria Revenue Market Share by Countries in 2016 Figure Germany Drugs for Malaria Sales and Growth (2012-2017) Figure UK Drugs for Malaria Sales and Growth (2012-2017) Figure France Drugs for Malaria Sales and Growth (2012-2017) Figure Russia Drugs for Malaria Sales and Growth (2012-2017) Figure Italy Drugs for Malaria Sales and Growth (2012-2017) Figure Asia-Pacific Drugs for Malaria Revenue and Growth (2012-2017) Table Asia-Pacific Drugs for Malaria Sales by Countries (2012-2017) Table Asia-Pacific Drugs for Malaria Sales Market Share by Countries (2012-2017) Table Asia-Pacific Drugs for Malaria Sales Market Share by Countries (2012-2017) Table Asia-Pacific Drugs for Malaria Revenue by Countries (2012-2017) Table Asia-Pacific Drugs for Malaria Revenue Market Share by Countries (2012-2017) Figure China Drugs for Malaria Sales and Growth (2012-2017) Figure Japan Drugs for Malaria Sales and Growth (2012-2017) Figure Korea Drugs for Malaria Sales and Growth (2012-2017) Figure India Drugs for Malaria Sales and Growth (2012-2017) Figure Southeast Asia Drugs for Malaria Sales and Growth (2012-2017) Figure South America Drugs for Malaria Revenue and Growth (2012-2017) Table South America Drugs for Malaria Sales by Countries (2012-2017) Table South America Drugs for Malaria Sales Market Share by Countries (2012-2017) Figure South America Drugs for Malaria Sales Market Share by Countries in 2016 Table South America Drugs for Malaria Revenue by Countries (2012-2017) Table South America Drugs for Malaria Revenue Market Share by Countries (2012-2017) Figure South America Drugs for Malaria Revenue Market Share by Countries in 2012 Figure South America Drugs for Malaria Revenue Market Share by Countries in 2016 Figure Brazil Drugs for Malaria Sales and Growth (2012-2017) Figure Argentina Drugs for Malaria Sales and Growth (2012-2017) Figure Columbia Drugs for Malaria Sales and Growth (2012-2017) Figure Middle East and Africa Drugs for Malaria Revenue and Growth (2012-2017) Table Middle East and Africa Drugs for Malaria Sales by Countries (2012-2017) Table Middle East and Africa Drugs for Malaria Sales Market Share by Countries (2012-2017) Figure Middle East and Africa Drugs for Malaria Sales Market Share by Countries in 2016 Table Middle East and Africa Drugs for Malaria Revenue by Countries (2012-2017) Table Middle East and Africa Drugs for Malaria Revenue Market Share by Countries (2012-2017) Figure Middle East and Africa Drugs for Malaria Revenue Market Share by Countries in 2012 Figure Middle East and Africa Drugs for Malaria Revenue Market Share by Countries in 2016 Figure Saudi Arabia Drugs for Malaria Sales and Growth (2012-2017) Figure UAE Drugs for Malaria Sales and Growth (2012-2017) Figure Egypt Drugs for Malaria Sales and Growth (2012-2017) Figure Nigeria Drugs for Malaria Sales and Growth (2012-2017) Figure South Africa Drugs for Malaria Sales and Growth (2012-2017) Table Global Drugs for Malaria Sales by Type (2012-2017) Table Global Drugs for Malaria Sales Share by Type (2012-2017) Table Global Drugs for Malaria Revenue by Type (2012-2017) Table Global Drugs for Malaria Revenue Share by Type (2012-2017) Figure Global Aryl Aminoalcohol Compounds Sales Growth (2012-2017) Figure Global Aryl Aminoalcohol Compounds Price (2012-2017) Figure Global Antifolate Compounds Sales Growth (2012-2017) Figure Global Antifolate Compounds Price (2012-2017) Figure Global Artemisinin Compounds Sales Growth (2012-2017) Figure Global Artemisinin Compounds Price (2012-2017) Table Global Drugs for Malaria Sales by Application (2012-2017) Table Global Drugs for Malaria Sales Share by Application (2012-2017) Figure Global Prevention Sales Growth (2012-2017) Figure Global Treatment Sales Growth (2012-2017) Figure Global Other Sales Growth (2012-2017) Figure Global Drugs for Malaria Sales, Revenue and Growth Rate (2017 -2022) Table Global Drugs for Malaria Sales Forecast by Regions (2017-2022) Table Global Drugs for Malaria Market Share Forecast by Regions (2017-2022) Figure North America Sales Drugs for Malaria Market Forecast (2017-2022) Figure Europe Sales Drugs for Malaria Market Forecast (2017-2022) Figure Asia-Pacific Sales Drugs for Malaria Market Forecast (2017-2022) Figure South America Sales Drugs for Malaria Market Forecast (2017-2022) Figure Middle East and Africa Sales Drugs for Malaria Market Forecast (2017-2022) Table Global Drugs for Malaria Sales Forecast by Type (2017-2022) Table Global Drugs for Malaria Market Share Forecast by Type (2017-2022) Table Global Drugs for Malaria Sales Forecast by Application (2017-2022) Table Global Drugs for Malaria Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List